| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 12 | 0 | 0 | 12 |
| 5-hydroxytryptamine receptor 3E | 0 | 3 | 0 | 3 |
| acetylcholinesterase | 7 | 0 | 0 | 7 |
| TDP1 protein | 28 | 0 | 0 | 28 |
| cytochrome P450 2D6 | 21 | 0 | 0 | 21 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 16 | 0 | 0 | 16 |
| cytochrome P450 2D6 isoform 1 | 13 | 0 | 0 | 13 |
| cellular tumor antigen p53 isoform a | 7 | 0 | 0 | 7 |
| cytochrome P450 2C19 precursor | 8 | 0 | 0 | 8 |
| cytochrome P450 2C9 precursor | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 11 | 0 | 0 | 11 |
| thyroid hormone receptor beta isoform 2 | 20 | 0 | 0 | 20 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 | 14 | 0 | 0 | 14 |
| cytochrome P450 3A4 isoform 1 | 13 | 0 | 0 | 13 |
| muscarinic acetylcholine receptor M1 | 16 | 0 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit pi | 13 | 4 | 2 | 19 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 7 | 1 | 0 | 8 |
| ATP-binding cassette sub-family C member 3 | 0 | 22 | 0 | 22 |
| Multidrug resistance-associated protein 4 | 0 | 23 | 0 | 23 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Bile salt export pump | 0 | 29 | 0 | 29 |
| Beta-1 adrenergic receptor | 0 | 5 | 1 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 14 | 11 | 27 |
| 5-hydroxytryptamine receptor 2C | 0 | 18 | 2 | 21 |
| D(2) dopamine receptor | 0 | 20 | 1 | 22 |
| 5-hydroxytryptamine receptor 2A | 0 | 23 | 3 | 27 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 13 | 4 | 2 | 19 |
| Alpha-1B adrenergic receptor | 0 | 13 | 1 | 14 |
| Gamma-aminobutyric acid receptor subunit delta | 13 | 4 | 2 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 13 | 4 | 3 | 20 |
| D | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 26 | 5 | 34 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 13 | 4 | 2 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 13 | 4 | 2 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 13 | 4 | 2 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 13 | 4 | 2 | 19 |
| Alpha-1D adrenergic receptor | 0 | 12 | 1 | 14 |
| 5-hydroxytryptamine receptor 2A | 0 | 26 | 4 | 31 |
| 5-hydroxytryptamine receptor 2C | 0 | 27 | 2 | 29 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 13 | 4 | 2 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 13 | 4 | 2 | 19 |
| 5-hydroxytryptamine receptor 1B | 0 | 20 | 2 | 23 |
| 5-hydroxytryptamine receptor 1D | 0 | 11 | 3 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 13 | 4 | 2 | 19 |
| 5-hydroxytryptamine receptor 1F | 0 | 10 | 2 | 13 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 17 | 2 | 19 |
| Sodium-dependent serotonin transporter | 0 | 37 | 7 | 45 |
| 5-hydroxytryptamine receptor 7 | 0 | 9 | 2 | 11 |
| 5-hydroxytryptamine receptor 7 | 0 | 9 | 1 | 11 |
| Alpha-1B adrenergic receptor | 0 | 5 | 1 | 9 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 6 | 0 | 11 |
| 5-hydroxytryptamine receptor 2B | 0 | 20 | 2 | 23 |
| Alpha-1A adrenergic receptor | 0 | 16 | 1 | 17 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 1 | 5 |
| Histamine H2 receptor | 9 | 4 | 0 | 15 |
| 5-hydroxytryptamine receptor 6 | 0 | 18 | 1 | 20 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 11 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 13 | 4 | 3 | 20 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 13 | 4 | 2 | 19 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 13 | 4 | 3 | 20 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 0 | 10 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 0 | 10 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 0 | 10 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 0 | 10 |
| 5-hydroxytryptamine receptor 3D | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 0 | 10 |
| 5-hydroxytryptamine receptor 3C | 0 | 3 | 0 | 3 |
| GABA theta subunit | 13 | 4 | 2 | 19 |
| Canalicular multispecific organic anion transporter 1 | 0 | 21 | 0 | 21 |
| Gamma-aminobutyric acid receptor subunit epsilon | 13 | 4 | 2 | 19 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 0 | 10 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
| Chain A, HADH2 protein | 13 | 0 | 0 | 13 |
| Chain B, HADH2 protein | 13 | 0 | 0 | 13 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
| Chain A, 2-oxoglutarate Oxygenase | 15 | 0 | 0 | 15 |
| Chain A, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
| Chain M, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
| Olfactory receptor class A-like protein 1 | 0 | 0 | 1 | 1 |
| Luciferase | 7 | 0 | 0 | 7 |
| endonuclease IV | 4 | 0 | 0 | 4 |
| thioredoxin reductase | 22 | 0 | 0 | 22 |
| RGS12 | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 13 | 0 | 0 | 13 |
| NFKB1 protein, partial | 7 | 0 | 0 | 7 |
| GLS protein | 19 | 0 | 0 | 19 |
| Microtubule-associated protein tau | 12 | 0 | 0 | 12 |
| Thrombopoietin | 4 | 0 | 0 | 4 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
| apical membrane antigen 1, AMA1 | 5 | 0 | 0 | 5 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 13 | 0 | 0 | 13 |
| euchromatic histone-lysine N-methyltransferase 2 | 32 | 0 | 0 | 32 |
| Bloom syndrome protein isoform 1 | 10 | 0 | 0 | 10 |
| lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 isoform 1 | 7 | 0 | 0 | 7 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 10 | 0 | 0 | 10 |
| intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
| chromobox protein homolog 1 | 24 | 0 | 0 | 24 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 6 | 0 | 0 | 6 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| geminin | 28 | 0 | 0 | 28 |
| M-phase phosphoprotein 8 | 9 | 0 | 0 | 9 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| lamin isoform A-delta10 | 21 | 0 | 0 | 21 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 31 | 5 | 37 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| ATP-dependent phosphofructokinase | 18 | 0 | 0 | 18 |
| 5-hydroxytryptamine receptor 6 | 0 | 5 | 2 | 7 |
| Sodium-dependent serotonin transporter | 0 | 17 | 2 | 20 |
| 5-hydroxytryptamine receptor 5A | 0 | 5 | 2 | 7 |
| 5-hydroxytryptamine receptor 5B | 0 | 5 | 2 | 7 |
| 5-hydroxytryptamine receptor 3A | 0 | 8 | 2 | 10 |
| 5-hydroxytryptamine receptor 4 | 0 | 5 | 2 | 7 |
| 5-hydroxytryptamine receptor 3B | 0 | 8 | 2 | 10 |
| RAR-related orphan receptor gamma | 21 | 0 | 0 | 21 |
| GLI family zinc finger 3 | 25 | 0 | 0 | 25 |
| AR protein | 27 | 0 | 0 | 27 |
| aldehyde dehydrogenase 1 family, member A1 | 21 | 0 | 0 | 21 |
| nuclear receptor subfamily 1, group I, member 3 | 20 | 0 | 0 | 20 |
| progesterone receptor | 12 | 0 | 0 | 12 |
| retinoic acid nuclear receptor alpha variant 1 | 23 | 0 | 0 | 23 |
| estrogen-related nuclear receptor alpha | 24 | 0 | 0 | 24 |
| pregnane X nuclear receptor | 22 | 0 | 0 | 22 |
| estrogen nuclear receptor alpha | 33 | 0 | 0 | 33 |
| aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 17 | 0 | 0 | 17 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 21 | 0 | 0 | 21 |
| dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
| lethal factor (plasmid) | 9 | 0 | 0 | 9 |
| Cytochrome P450 1A1 | 0 | 5 | 1 | 6 |
| Cytochrome P450 1A2 | 0 | 6 | 0 | 8 |
| ATP-dependent translocase ABCB1 | 0 | 7 | 1 | 9 |
| Cytochrome P450 3A4 | 0 | 10 | 0 | 12 |
| Cytochrome P450 2D6 | 0 | 13 | 1 | 14 |
| Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
| Cytochrome P450 2C9 | 0 | 11 | 0 | 12 |
| Potassium voltage-gated channel subfamily A member 2 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 6 | 0 | 0 | 1 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 9 | 0 | 10 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 0 | 1 | 1 |
| Cytochrome P450 2C19 | 0 | 8 | 0 | 9 |
| Potassium voltage-gated channel subfamily C member 1 | 0 | 0 | 1 | 1 |
| Beta-secretase 1 | 0 | 4 | 1 | 5 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Cytochrome P450 1B1 | 0 | 5 | 1 | 6 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 8 | 0 | 0 | 8 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| Translocator protein | 0 | 1 | 1 | 2 |
| D(3) dopamine receptor | 0 | 5 | 0 | 6 |
| Alpha-2B adrenergic receptor | 0 | 9 | 1 | 11 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 9 | 1 | 11 |
| Alpha-2A adrenergic receptor | 0 | 9 | 1 | 11 |
| Sodium-dependent dopamine transporter | 0 | 17 | 0 | 17 |
| Alpha-1D adrenergic receptor | 0 | 16 | 1 | 20 |
| 5-hydroxytryptamine receptor 1D | 0 | 5 | 1 | 8 |
| 5-hydroxytryptamine receptor 1B | 0 | 6 | 3 | 10 |
| Alpha-1A adrenergic receptor | 0 | 6 | 2 | 11 |
| 5-hydroxytryptamine receptor 5A | 0 | 4 | 0 | 5 |
| 5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
| D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 24 | 0 | 24 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Transporter | 0 | 15 | 0 | 15 |
| Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
| Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
| Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
| Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 21 | 0 | 0 | 21 |
| glucocorticoid receptor [Homo sapiens] | 22 | 0 | 0 | 22 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
| heat shock protein beta-1 | 5 | 0 | 0 | 5 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Cyclin-dependent kinase 1 | 0 | 3 | 0 | 3 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 7 | 1 | 0 | 9 |
| Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 2 | 0 | 2 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
| Ataxin-2 | 16 | 0 | 0 | 16 |
| peroxisome proliferator activated receptor gamma | 13 | 0 | 0 | 13 |
| nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
| Bromodomain-containing protein 4 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 0 | 4 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 5 | 0 | 5 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| USP1 protein, partial | 16 | 0 | 0 | 16 |
| arylsulfatase A | 12 | 0 | 0 | 12 |
| D(1A) dopamine receptor | 16 | 0 | 0 | 16 |
| atrial natriuretic peptide receptor 2 precursor | 6 | 0 | 0 | 6 |
| serine/threonine-protein kinase mTOR isoform 1 | 8 | 0 | 0 | 8 |
| Solute carrier family 22 member 1 | 0 | 8 | 0 | 10 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 4 | 0 | 18 | 0 | 18 |
| Albumin | 0 | 0 | 3 | 3 |
| High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 19 | 0 | 19 |
| Muscarinic acetylcholine receptor M2 | 0 | 12 | 1 | 14 |
| Muscarinic acetylcholine receptor M4 | 0 | 11 | 0 | 12 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 13 | 0 | 13 |
| Alpha-2A adrenergic receptor | 0 | 16 | 2 | 20 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 14 | 1 | 16 |
| Angiotensin-converting enzyme | 0 | 10 | 0 | 10 |
| Alpha-2B adrenergic receptor | 0 | 18 | 1 | 21 |
| Alpha-2C adrenergic receptor | 0 | 15 | 2 | 19 |
| Muscarinic acetylcholine receptor M3 | 0 | 12 | 1 | 14 |
| D(1A) dopamine receptor | 0 | 11 | 1 | 14 |
| D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 3 |
| Histamine H2 receptor | 0 | 8 | 0 | 9 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| Histamine H1 receptor | 0 | 16 | 0 | 17 |
| D(3) dopamine receptor | 0 | 14 | 0 | 14 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 4 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 6 | 0 | 0 | 6 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 3 | 0 | 3 |
| Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 1 | 4 |
| Sodium-dependent dopamine transporter | 0 | 27 | 4 | 31 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 18 | 0 | 18 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 1 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 1 | 6 |
| Sodium channel protein type 5 subunit alpha | 0 | 5 | 0 | 5 |
| Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 2 | 4 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 10 | 0 | 10 |
| Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
| Histamine H3 receptor | 0 | 3 | 0 | 3 |
| Sodium channel protein type 10 subunit alpha | 0 | 3 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
| Vasopressin V2 receptor | 0 | 3 | 1 | 5 |
| Oxytocin receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 0 | 2 | 2 |
| Vasopressin V1a receptor | 0 | 2 | 2 | 4 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
| Translocator protein | 0 | 1 | 0 | 2 |
| Oxytocin receptor | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| ATAD5 protein, partial | 10 | 0 | 0 | 10 |
| 67.9K protein | 5 | 0 | 0 | 5 |
| activating transcription factor 6 | 8 | 0 | 0 | 8 |
| histone acetyltransferase KAT2A isoform 1 | 10 | 0 | 0 | 10 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 6 | 0 | 0 | 6 |
| Chain A, Cruzipain | 6 | 0 | 0 | 6 |
| DNA polymerase kappa isoform 1 | 10 | 0 | 0 | 10 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 4 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 5 |
| Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
| Integrin alpha-5 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 2 |
| Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| retinoid X nuclear receptor alpha | 19 | 0 | 0 | 19 |
| farnesoid X nuclear receptor | 9 | 0 | 0 | 9 |
| thyroid stimulating hormone receptor | 11 | 0 | 0 | 11 |
| atrial natriuretic peptide receptor 1 precursor | 4 | 0 | 0 | 4 |
| Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 6 |
| Carbonic anhydrase 2 | 0 | 3 | 1 | 8 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 5 | 2 | 7 |
| Adenosine receptor A3 | 0 | 3 | 1 | 4 |
| Replicase polyprotein 1ab | 0 | 5 | 2 | 7 |
| Acetylcholinesterase | 0 | 8 | 0 | 8 |
| Adenosine receptor A1 | 0 | 3 | 0 | 7 |
| Amine oxidase [flavin-containing] B | 0 | 7 | 0 | 8 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 4 | 2 | 7 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 3 | 1 | 6 |
| Adenosine receptor A2a | 0 | 3 | 0 | 8 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 0 | 2 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 2 | 2 | 4 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 1 | 5 |
| Guanine deaminase | 0 | 1 | 0 | 2 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| PPM1D protein | 6 | 0 | 0 | 6 |
| mitogen-activated protein kinase 1 | 12 | 0 | 0 | 12 |
| Interferon beta | 17 | 0 | 0 | 17 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Vitamin D3 receptor | 0 | 2 | 3 | 8 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 3 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| Vitamin D3 receptor | 0 | 0 | 2 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 3 | 0 | 3 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| Fumarate hydratase | 9 | 0 | 0 | 9 |
| EWS/FLI fusion protein | 14 | 0 | 0 | 14 |
| G | 12 | 0 | 0 | 12 |
| polyprotein | 9 | 0 | 0 | 9 |
| L-ornithine N(5)-monooxygenase | 0 | 1 | 1 | 2 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 2 | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 12 | 0 | 0 | 12 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 3 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 1 | 3 |
| Nuclear receptor subfamily 4 group A member 1 | 0 | 0 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase epsilon | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 6 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
| Tryptophan 2,3-dioxygenase | 0 | 2 | 0 | 3 |
| Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN | 0 | 1 | 0 | 1 |
| Heat shock factor protein 1 | 0 | 1 | 1 | 2 |
| Tyrosine-protein phosphatase non-receptor type 11 | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein phosphatase eta | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 12 | 0 | 0 | 12 |
| Regulator of G-protein signaling 17 | 0 | 1 | 0 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 15 | 0 | 1 | 0 | 1 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L5 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 12 | 0 | 0 | 12 |
| interleukin 8 | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| peroxisome proliferator-activated receptor delta | 13 | 0 | 0 | 13 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
| Histone H2A.x | 8 | 0 | 0 | 8 |
| Cellular tumor antigen p53 | 14 | 0 | 0 | 14 |
| Nuclear receptor ROR-gamma | 6 | 0 | 0 | 6 |
| 15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
| survival motor neuron protein isoform d | 7 | 0 | 0 | 7 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 5 | 0 | 0 | 5 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
| Tryptophan 5-hydroxylase 1 | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| Aromatase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 8 | 0 | 2 | 10 |
| Sigma intracellular receptor 2 | 0 | 6 | 0 | 6 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
| caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
| estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
| caspase-3 | 6 | 0 | 0 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 12 | 0 | 0 | 12 |
| Spike glycoprotein | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 11 | 0 | 0 | 11 |
| Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
| Procathepsin L | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1a | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| Trypanothione reductase | 0 | 2 | 0 | 2 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-6 | 0 | 0 | 1 | 1 |
| Envelope glycoprotein | 0 | 0 | 4 | 4 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
| Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
| Amyloid-beta precursor protein | 0 | 3 | 0 | 3 |
| Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 0 | 4 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 4 | 0 | 4 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
| Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| GALC protein | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| IDH1 | 7 | 0 | 0 | 7 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
| Glutamate receptor 1 | 1 | 1 | 0 | 3 |
| Glutamate receptor 3 | 1 | 1 | 0 | 3 |
| Glutamate receptor 4 | 1 | 1 | 0 | 3 |
| Histamine H1 receptor | 0 | 0 | 0 | 1 |
| Histamine H3 receptor | 0 | 0 | 0 | 1 |
| glp-1 receptor, partial | 7 | 0 | 0 | 7 |
| Smad3 | 7 | 0 | 0 | 7 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| Alpha-synuclein | 2 | 2 | 0 | 4 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 5 | 0 | 0 | 5 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily C member 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 4 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
| D(4) dopamine receptor | 0 | 3 | 0 | 3 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| Ricin | 0 | 1 | 0 | 1 |
| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Chain A, Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| CDC-like kinase 1, isoform CRA_c | 0 | 0 | 0 | 1 |
| [Tau protein] kinase | 0 | 1 | 0 | 1 |
| dual specificity protein kinase CLK4 | 1 | 0 | 0 | 1 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Dual specificity protein kinase CLK2 | 0 | 1 | 0 | 1 |
| Dual specificity protein kinase CLK3 | 0 | 1 | 0 | 1 |
| Dual specificity protein kinase CLK4 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 3 | 0 | 1 | 0 | 1 |
| Cyclin-T1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B2 | 0 | 2 | 0 | 2 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 3 | 0 | 3 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 4 | 1 | 5 |
| Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase pim-1 | 0 | 2 | 1 | 3 |
| G2/mitotic-specific cyclin-B1 | 0 | 2 | 0 | 2 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 5 | 0 | 6 |
| Dual specificity protein kinase CLK1 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 2 | 0 | 2 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Neuromedin-B receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 2 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 3 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 1 | 0 | 1 |
| Protein kinase C iota type | 0 | 1 | 0 | 1 |
| Casein kinase I isoform delta | 0 | 1 | 0 | 1 |
| Casein kinase I isoform epsilon | 0 | 1 | 0 | 1 |
| Dual specificity protein kinase CLK1 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 2 | 0 | 2 |
| Cyclin-dependent kinase 7 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 9 | 0 | 1 | 0 | 1 |
| Cyclin-H | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 1 | 0 | 1 |
| Cyclin-A1 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Cyclin-dependent-like kinase 5 | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Aldehyde oxidase | 0 | 1 | 0 | 1 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 2 | 0 | 2 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase pim-3 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase haspin | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 2 | 0 | 2 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 4 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 2 | 0 | 2 |
| ClpP | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 5 | 0 | 0 | 5 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 2 | 0 | 2 |
| Snq2p | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 2 | 3 |
| Type-2 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 0 | 2 |
| Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 2 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| G protein-coupled receptor GPR35 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 2 |
| Vesicular glutamate transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 3 | 2 | 5 |
| Histamine H3 receptor | 0 | 0 | 1 | 2 |
| Integrin beta-3 | 5 | 0 | 0 | 5 |
| Integrin alpha-IIb | 5 | 0 | 0 | 5 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 2 | 0 | 2 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| pyruvate kinase | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 4 | 0 | 0 | 4 |
| Polyphenol oxidase 2 | 0 | 1 | 1 | 6 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 5 |
| Plasma kallikrein | 0 | 0 | 0 | 4 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 5 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 5 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 5 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 5 |
| Carbonic anhydrase | 0 | 0 | 0 | 4 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 5 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 4 |
| Large neutral amino acids transporter small subunit 1 | 0 | 4 | 0 | 5 |
| SLC16A10 protein | 0 | 0 | 0 | 4 |
| Carbonic anhydrase 9 | 0 | 2 | 1 | 7 |
| Carbonic anhydrase | 0 | 0 | 0 | 4 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 4 |
| Carbonic anhydrase | 0 | 0 | 0 | 4 |
| Carbonic anhydrase | 0 | 0 | 0 | 4 |
| Carbonic anhydrase | 0 | 0 | 0 | 4 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 4 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 4 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 4 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 5 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 5 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1E | 0 | 2 | 0 | 3 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Cysteinyl leukotriene receptor 1 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 4 | 0 | 4 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 2 | 0 | 2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 4 | 2 | 6 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 2 | 2 | 4 |
| Melatonin receptor type 1B | 0 | 4 | 2 | 6 |
| Melatonin receptor type 1C | 0 | 2 | 2 | 4 |
| Melatonin receptor type 1B | 0 | 2 | 2 | 4 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 1 | 3 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 0 | 0 | 1 |
| Heparanase | 0 | 0 | 1 | 1 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Albumin | 0 | 0 | 2 | 2 |
| Stromelysin-1 | 0 | 3 | 0 | 3 |
| Matrilysin | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
| Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
| Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
| Beta-adrenergic receptor kinase 1 | 0 | 1 | 0 | 1 |
| Beta-adrenergic receptor kinase 1 | 0 | 1 | 1 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
| G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
| G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 2 | 0 | 2 |
| E3 ubiquitin-protein ligase XIAP | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
| Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, APH(2')-Id | 0 | 1 | 0 | 1 |
| glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| hexokinase | 0 | 1 | 0 | 1 |
| galactokinase | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
| NUAK family SNF1-like kinase 1 | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Arginase | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 2 | 3 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Cationic trypsin | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Chymotrypsin-like elastase family member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Protein E6 | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Interstitial collagenase | 0 | 1 | 1 | 2 |
| Phospholipase A2 | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Epoxide hydrolase 1 | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Yes | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 0 | 1 |
| Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 3 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Hepatocyte growth factor receptor | 0 | 1 | 0 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Alpha-amylase 1A | 0 | 1 | 0 | 1 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Sialidase | 0 | 1 | 0 | 1 |
| Malate dehydrogenase | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 2 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 3 | 0 | 3 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 2 |
| G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Chymotrypsinogen B | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha' | 0 | 2 | 0 | 2 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
| Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase receptor UFO | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 0 | 2 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Macrophage metalloelastase | 0 | 1 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek2 | 0 | 1 | 0 | 1 |
| Oligo-1,6-glucosidase IMA1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK1 | 0 | 1 | 0 | 1 |
| Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit beta | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha | 0 | 2 | 0 | 2 |
| Urease subunit beta | 0 | 3 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 3 |
| Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
| Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
| Cyclin homolog | 0 | 1 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
| Focal adhesion kinase 1 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
| ELAV-like protein 3 | 0 | 1 | 0 | 1 |
| ELAV-like protein 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase N1 | 0 | 1 | 0 | 1 |
| Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha 3 | 0 | 2 | 0 | 2 |
| Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C21 | 0 | 2 | 0 | 2 |
| Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
| Aurora kinase B | 0 | 1 | 0 | 1 |
| Chymotrypsin-C | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek6 | 0 | 1 | 0 | 1 |
| NADPH oxidase 4 | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
| Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
| Chain A, Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Chain A, Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B10 | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 1 | 1 |
| Orexin receptor type 1 | 0 | 2 | 0 | 4 |
| Orexin receptor type 2 | 0 | 2 | 0 | 3 |
| Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Vpr | 1 | 0 | 0 | 1 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 2 | 4 |
| Cannabinoid receptor 1 | 0 | 2 | 2 | 8 |
| Cannabinoid receptor 2 | 0 | 2 | 1 | 6 |
| Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
| Cannabinoid receptor 2 | 0 | 0 | 1 | 1 |
| C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| N-arachidonyl glycine receptor | 0 | 1 | 0 | 1 |
| G-protein coupled bile acid receptor 1 | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 55 | 0 | 0 | 1 | 1 |
| Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
| Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
| Carboxypeptidase M | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 3 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Transthyretin | 0 | 1 | 0 | 3 |
| Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
| Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
| Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 4 | 4 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Tryprostatin B synthase | 0 | 0 | 0 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| guanine nucleotide-binding protein subunit alpha-15 | 0 | 1 | 1 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| D(3) dopamine receptor isoform e | 1 | 0 | 0 | 1 |
| trace amine-associated receptor 1 | 0 | 1 | 1 | 2 |
| Phenylethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Dopamine beta-hydroxylase | 0 | 0 | 0 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
| Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |